Metadon Dne Pharma (Methadone Hydrochloride)

Methadone is a full agonist at the μ‑opioid receptor. By binding to this receptor it activates the same pathways that endogenous opioids use, providing analgesia and reducing cravings and withdrawal symptoms in people dependent on opioids.

The dose of methadone is individualized. A qualified prescriber determines the appropriate starting amount and any subsequent adjustments based on the patient’s clinical condition, prior opioid exposure, and response to therapy.

Data on methadone use during pregnancy and lactation are limited. It is generally prescribed only when the benefits outweigh potential risks, and treatment decisions should be made in consultation with a maternal‑fetal medicine specialist.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both methadone and buprenorphine are used for opioid dependence, but methadone is a full μ‑opioid agonist with a longer half‑life, while buprenorphine is a partial agonist with a ceiling effect on respiratory depression. Choice depends on patient history, treatment setting, and risk‑benefit considerations.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Metadon Dne Pharma is administered orally. The tablet (or other oral dosage form) is swallowed whole with water, usually once daily, unless the prescriber advises a different schedule based on the individual treatment plan.

The most serious risks include respiratory depression, especially when combined with other depressants, QT interval prolongation that can lead to cardiac arrhythmias, severe hypotension, and rare allergic reactions. Patients should be monitored closely for these events.

Methadone should be avoided in individuals with known hypersensitivity to methadone, uncontrolled severe respiratory disease, significant cardiac conduction abnormalities (e.g., prolonged QT), or in patients for whom opioid therapy is contraindicated.